In-vitro metabolite profiling of by LC-MS/MS Tejaswini Kailas Jadhav MS (Pharmaceutical Analysis) NIPER-A.

Slides:



Advertisements
Similar presentations
Chemistry Dept, UCONN Identification of Drug Metabolites via Mass Spectrometry Besnik Bajrami Chem 395.
Advertisements

DBS – Process & Review GHANSHYAM. 3Rs No need to explain…………… GOAL IS ANIMAL SAVING R1 REPLACEMENT R2 REFINEMENT R3 REDUCTION.
Improvements in Mass Spectrometry for Life Science Research – Does Agilent Have the Answer? Ashley Sage PhD.
HPLC Coupled with Quadrupole Mass Spectrometry and Forensic Analysis of Cocaine.
Metabolomics DNA RNA Protein Biochemicals (Metabolites) Genomics – 25,000 Genes Transcriptomics – 100,000 Transcripts Metabolomics – 2,800 Compounds Proteomics.
Microarrays: Tools for Proteomics
Simultaneous Detection of GHB, Ketamine and Flunitrazepam Using Hair Samples Samantha Olson CHEM 4101 December 13,2010 Samantha Olson CHEM 4101 December.
Metabolite Kinetics II
LC/MS WORKSHOP IOWA STATE UNIVERSITY Kamel Harrata  Instrument Description  Data Acquisition  Data Processing.
Investigation of Oxidative and Conjugative Metabolism Reactions with Liquid Chromatography / Accurate Mass High Resolution Mass Spectrometry Maciej Bromirski.
HOW MASS SPECTROMETRY CAN IMPROVE YOUR RESEARCH
Drug Detoxification Dr. Howaida Supervised by : Prepared by:
Mass Spectrometry Mass spectrometry (MS) is not true “spectroscopy” because it does not involve the absorption of electromagnetic radiation to form an.
PHARMACEUTICAL CHEMISTRY RESEARCH PROJECTS 2013 ;.
Metabolomics 5/2/2014. ‘Omics Family Tree W. M. Claudino, et al., Journal of Clinical Oncology, 2007, 25(19), pp /2/2014.
2007 GeneSpring MS GeneSpring for Metabolite BioMarker Analysis using Mass Spectrometry data Agilent Q-TOF VIP Visit Jan 16-17, 2007 Santa Clara, CA Thon.
Year 12 Chemistry Unit 3 – AOS 1 Chemical Analysis.
Drug bioactivation predicting enzyme based biosensor
Pharmaceutical analysis Bioavailability studies Drug metabolism studies, pharmacokinetics Characterization of potential drugs Drug degradation product.
Luděk Bláha, PřF MU, RECETOX BIOMARKERS AND TOXICITY MECHANISMS 11 – BIOMARKERS of EXPOSURE and SUSCEPTIBILITY.
Center for Human Health and the Environment
Finding a Needle in a Haystack: Using High Resolution Mass Spectrometry in Targeted and Non Targeted Searching for Food Contaminants Erik Verschuuren.
DR.R.MEHER ALI, M.D. PROFESSOR OF CLINICAL PHARMACOLOGY MADRAS MEDICAL COLLEGE CHENNAI.
Section 1, Lecture 4 Phase I reactions-oxidative occur in the endoplasmic reticulum of liver (microsomal fractions) - catalyzed by the microsomal.
Epigenetic Processes from a Molecular Perspective INBRE Meeting 2/16/10.
液相層析質譜分析 LC-MS Method development and Analyte Identification 授課教師:賴滄海教授 授課教師:賴滄海教授
Overview of Mass Spectrometry
ERT 207 ANALYTICAL CHEMISTRY Alina Rahayu Mohamed PPK Bioproses Universiti Malaysia Perlis.
Dr Saleha Shamsudin. 1.INTRODUCTION Topics to be covered: 1.1 INTRODUCTION TO METHODS IN ANALYTICAL CHEMISTRY 1.2 STEPS IN QUANTITATIVE ANALYSIS.
Salamanca, March 16th 2010 Participants: Laboratori de Proteomica-HUVH Servicio de Proteómica-CNB-CSIC Participants: Laboratori de Proteomica-HUVH Servicio.
Metabolomics MS and Data Analysis PCB 5530 Tom Niehaus Fall 2015.
Detoxification Chemicals entering body (mostly via food) must pass through liver.
GARLIC AND HEALTH in vivo Metabolism of DADS 4 th October 2001 Study of in vivo Diallyl disulfide Metabolism Aims of the study : –To determine the pharmacokinetic.
Page 1 NMR Services —by Creative Biostructure. Page 2 NMR spectroscopy is a key analytical technique for structure elucidation of a wide range of materials.
Xenobiotic metabolites The organism removes xenobiotics by xenobiotic metabolism, consisting of deactivation/activation and excretion of xenobiotics, which.
Multi-Analyte LC-MS/MS Methods – Best Practice.
In Vitro Metabolism and Prediction of Drug-Drug Interaction of the Calcimimetic Agent Cinacalcet HCl Manoj Bajpai, Joel Esmay, Victor Chi, Mike Hayashi,
A B C Figure S1. LC-MS and LC-MS/MS data on [M+H]+ ion with 837 m/z formed when MDI is reacted with oxidized glutathione. Following reactivity of MDI with.
Mimicking Oxidative Metabolism “OxMet” using ROXY EC System
LC-MS/MS Identification of Impurities Present in Synthetic Peptide Drugs Dr Anna Meljon*, Dr Alan Thompson, Dr Osama Chahrour, and Dr John Malone Almac.
Mass spectrometry is one of the most important techniques used in today modern laboratories and especially chemical industry. Mass Spectrometry is the.
Time of Flight Analyzers
Mass Spectrometry Vs. Immunoassay
Mass Spectrometry Obaid M. Shaikh.
Nuclear magnetic resonance NMR spectroscopy is a key analytical technique for structure elucidation of a wide range of materials from small molecules to.
The average rate at which alcohol is eliminated from the body is ∼7 g/h, which translates to ∼1 drink/h. Alcohol undergoes first pass gastric metabolism.
C. Costa, R. Webb, V. Palitsin, M. Ismail, M. de Puit, S. Atkinson, M
Metabolomics Part 2 Mass Spectrometry
Volume 85, Issue 4, Pages (April 2014)
ADME/Tox PredictionTox Prediction. The characterization of Absorption, Distribution, Metabolism, and Excretion (also known as ADME) and Toxicity are essential.
The ABCs of Drug Testing
Phase-II Drug Metabolism Pharmaceutical Medicinal Chemistry-I
Human Health and Disease
Bioinformatics Solutions Inc.
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification  A. Bizzini, G. Greub 
Identification & Assessment of NPS: an European Network
V. Protein Chips 1. What is Protein Chips 2. How to Make Protein Chips
Microbiome: Metabolomics
Pure Carrier Gas Grades (subjective)
Metabolomics: Preanalytical Variables
Drug Detoxification Dr. Howaida Supervised by : Prepared by:
Legal Highs – Challenges in Clinical Analytics
Metabolism of Anabolic Androgenic Steroids
Identify and Investigate the role of enzymes.
Volume 85, Issue 4, Pages (April 2014)
Microbiome: Metabolomics
Method development for metabolites of CWA-related compounds in mussel and fish samples Hanna Niemikoski VERIFIN/ Hanna Niemikoski
The kynurenic pathway. The kynurenic pathway. The encircled metabolites were measured and symbols indicate method and biological sample, that is, LC-MS/MS.
The Role of the Toxicologist
Presentation transcript:

In-vitro metabolite profiling of by LC-MS/MS Tejaswini Kailas Jadhav MS (Pharmaceutical Analysis) NIPER-A

KEYWORDS

METABOLITE PROFILING Metabolites are the intermediates and products of metabolism. The measurement and interpretation of the endogenous metabolite profile from a biological sample (typically urine, serum, or biological tissue extract) have provided many opportunities to investigate drug and metabolite that are present in body.

DMPK studies is most important part during process of drug discovery, in-vitro ADMET screens, thereby accelerating the drug discovery process. DRUG DISCOVERY

Approaches in Metabolite profiling Metabolic stability Reaction phenotyping Metabolite identification Rate and nature of metabolism in in-vitro species Reactive metabolite formation Enzyme induction and enzyme inhibition-DDI

IN-SILICO PREDICTION Meta Print 2D METASITE SYBYL METEOR Metabol Expert

PROTEIN PRECIPITATION LIQUID-LIQUID EXTRACTION SOLID PHASE EXTRACTION EXTRACTION

MASS HPLC LC- NMR GC-MS LC- MS/MS LC-ICP- MS FT-IR RAMAN TOF Q-TOF ION TRAP QqQ ORBITRAP ANALYTICAL TECHNIQUES

LC-MS/MS Mass spectrometry plays a key role in drug metabolite identification, It has improved accuracy and stability, along with new data processing techniques, has improved the quality and productivity of metabolite identification processes. LC-MS/MS

Incubation of test drug sample with hepatocytes/HLM will lead to formation of Phase 1 (Oxidation / Reduction / hydrolysis) and Phase 2 conjugated metabolites. Which will be identified by validated LC-MS/MS method. Metabolism (percentage of test compound metabolized after a certain time) and qualitative determination of metabolite pattern (minor, intermediate, and major abundance of each metabolite) EXPECTED OUTCOMES

TEJASWINI KAILAS JADHAV MS(PHARMACEUTICAL ANALYSIS) NIPER-A